• CAT Number: I001324
  • CAS Number: 1346242-81-6
  • Molecular Formula: C25H30N6O2
  • Molecular Weight: 446.5
  • Purity: ≥95%
Inquiry Now

Erdafitinib,(CAT: I001324) is a potent and selective inhibitor of fibroblast growth factor receptor (FGFR) tyrosine kinases. By targeting FGFRs, erdafitinib interferes with aberrant signaling pathways involved in cell growth, survival, and angiogenesis. This pharmacologic action makes erdafitinib particularly effective against cancers harboring specific FGFR genetic alterations, such as FGFR2 fusions or mutations. Erdafitinib has demonstrated clinical efficacy in the treatment of metastatic urothelial carcinoma, providing a targeted therapeutic option for patients with these genetic alterations.

Catalog Number I001324
CAS Number 1346242-81-6


Molecular Formula


Purity 95%
Target FGFR
Solubility DMSO: ≥ 33 mg/mL
Storage -20°C
IC50 9/8.5/8.5/8.25 (pIC50, for FGFR1/2/3/4)
IUPAC Name N'-(3,5-dimethoxyphenyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]-N-propan-2-ylethane-1,2-diamine
InChI InChI=1S/C25H30N6O2/c1-17(2)26-8-9-31(20-10-21(32-4)13-22(11-20)33-5)19-6-7-23-24(12-19)29-25(15-27-23)18-14-28-30(3)16-18/h6-7,10-17,26H,8-9H2,1-5H3

<br />
1:Oncogenic Characterization and Pharmacologic Sensitivity of Activating Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations to the Selective FGFR Inhibitor Erdafitinib. Karkera JD, Martinez Cardona G, Bell K, Gaffney D, Portale JC, Santiago-Walker A, Moy C, King P, Sharp M, Bahleda R, Luo FR, Alvarez JD, Lorenzi MV, Platero SJ.Mol Cancer Ther. 2017 Apr 17. pii: molcanther.0518.2016. doi: 10.1158/1535-7163.MCT-16-0518. [Epub ahead of print] PMID: 28416604<br />
2:Discovery and pharmacological characterization of JNJ-42756493 (erdafitinib), a functionally selective small molecule FGFR family inhibitor. Perera TP, Jovcheva E, Mevellec L, Vialard J, De Lange D, Verhulst T, Paulussen C, Van De Ven K, King P, Freyne E, Rees DC, Squires M, Saxty G, Page M, Gilissen R, Murray CW, Ward G, Thompson NT, Newell DR, Cheng N, Xie L, Yang J, Platero SJ, Karkera JD, Moy C, Angibaud P, Laquerre S, Lorenzi MV.Mol Cancer Ther. 2017 Mar 24. pii: molcanther.0589.2016. doi: 10.1158/1535-7163.MCT-16-0589. [Epub ahead of print] PMID: 28341788

Request a Quote

Contact Us at MuseChem

We are committed to providing you with reliable, cost-effective solutions for your chemical needs, while ensuring your safety and comfort. Our team of experts is always available to answer your questions and help you navigate the complexities of the chemical industry.

Whether you're looking for a specific product or need help with a custom synthesis project, we're here to help you discover a new world of chemical possibilities. Contact us today to learn more about how we can assist you with all of your chemical needs.

Our goal is to make the process of ordering chemicals as seamless and hassle-free as possible. Let us know how we can assist you, and we'll get back to you as soon as possible. We look forward to hearing from you!